Sign in

CIK 0001869105

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

BridgeBio Oncology Therapeutics, Inc.

Sign in to watch
Ticker
BBOT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-702-0377
Business address
256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO, CA, 94080
Former names
Helix Acquisition Corp. II
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,628
in 2 filings, $4K under 10b5-1 plans

Net −$3,628. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-13 Cobo Marc Principal Accounting Officer Sale 10b5-1 −78 $2.37 $185 13,734
2026-10-21 Cobo Marc Principal Accounting Officer Shares withheld for taxes −203 $2.68 $544 13,812
2026-10-01 Cobo Marc Principal Accounting Officer Shares withheld for taxes −126 $3.94 $496 14,015
2026-09-10 Cobo Marc Principal Accounting Officer Grant or award +9,038 14,344
2026-09-10 Cobo Marc Principal Accounting Officer Shares withheld for taxes −203 $5.52 $1K 14,141
2026-09-10 Cobo Marc Principal Accounting Officer Grant or award · Stock Option (Right to Buy) +43,700 43,700
2026-07-01 Cobo Marc Principal Accounting Officer Shares withheld for taxes −125 $7.80 $975 5,306

Page 1 of 1 · 7 trades